Found: 68
Select item for more details and to access through your institution.
Stress testing the Centiloid: Precision and variability of PET quantification of amyloid pathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 8, p. 5102, doi. 10.1002/alz.13883
- By:
- Publication type:
- Article
Optimized dual-time-window protocols for quantitative [<sup>18</sup>F]flutemetamol and [<sup>18</sup>F]florbetaben PET studies.
- Published in:
- EJNMMI Research, 2013, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13550-019-0499-4
- By:
- Publication type:
- Article
Evaluation of tau deposition using <sup>18</sup>F-PI-2620 PET in MCI and early AD subjects—a MissionAD tau sub-study.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01048-x
- By:
- Publication type:
- Article
Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00836-1
- By:
- Publication type:
- Article
Early detection of amyloid load using 18F-florbetaben PET.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00807-6
- By:
- Publication type:
- Article
Colour vision impairment is associated with disease severity in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 9, p. 1207, doi. 10.1177/1352458513517591
- By:
- Publication type:
- Article
Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.
- Published in:
- Annals of Neurology, 2014, v. 75, n. 1, p. 98, doi. 10.1002/ana.24030
- By:
- Publication type:
- Article
Contribution of SPECT Measurements of D<sub>2</sub> and 5-HT<sub>2A</sub> Occupancy to the Clinical Development of the Antipsychotic SB-773812.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 4, p. 526, doi. 10.2967/jnumed.110.081885
- By:
- Publication type:
- Article
Characterization of the SPECT 5-HT<sub>2A</sub> Receptor Ligand <sup>123</sup>I-R91150 in Healthy Volunteers: Part 2--Ketanserin Displacement.
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 929
- By:
- Publication type:
- Article
Characterization of the SPECT 5-HT<sub>2A</sub> Receptor Ligand <sup>123</sup>I-R91150 in Healthy Volunteers: Part 1--Pseudoequilibrium Interval and Quantification Methods.
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 919
- By:
- Publication type:
- Article
Absolute Quantification in Dopaminergic Neurotransmission SPECT Using a Monte Carlo--Based Scatter Correction and Fully 3-Dimensional Reconstruction.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 9, p. 1497
- By:
- Publication type:
- Article
SPECT of Serotonin Transporters Using <sup>123</sup>I-ADAM: Optimal Imaging Time After Bolus Injection and Long-Term Test--Retest in Healthy Volunteers.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 8, p. 1301
- By:
- Publication type:
- Article
Restricted maximum likelihood estimation of PET neuroreceptor occupancy in the absence of a reference region.
- Published in:
- Medical Physics, 2011, v. 38, n. 5, p. 2558, doi. 10.1118/1.3578606
- By:
- Publication type:
- Article
CenTauR: Toward a universal scale and masks for standardizing tau imaging studies.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2023, v. 15, n. 3, p. 1, doi. 10.1002/dad2.12454
- By:
- Publication type:
- Article
Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a <sup>123</sup>I-ADAM SPECT study.
- Published in:
- Psychopharmacology, 2006, v. 189, n. 2, p. 145, doi. 10.1007/s00213-006-0540-y
- By:
- Publication type:
- Article
Converging evidence for a "gray‐zone" of amyloid burden and its relevance: The value of amyloid PET beyond dichotomization.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044786
- By:
- Publication type:
- Article
Quantitative thresholds for <sup>18</sup>F‐florbetaben PET for the detection of low amyloid load: Neuroimaging / Optimal neuroimaging measures for early detection.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042933
- By:
- Publication type:
- Article
O4‐12‐05: EVALUATION OF TAU DEPOSITION IN AMYLOID‐POSITIVE MCI OR MILD AD DEMENTIA SUBJECTS FROM THE ELENBECESTAT MISSION AD PROGRAM USING [<sup>18</sup> F]PI‐2620 PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1268, doi. 10.1016/j.jalz.2019.06.4810
- By:
- Publication type:
- Article
IC‐P‐040: EVALUATION OF TAU DEPOSITION IN AMYLOID POSITIVE MCI OR MILD‐AD DEMENTIA SUBJECTS FROM THE ELENBECESTAT MISSION AD PROGRAM USING [<sup>18</sup> F]PI‐2620 PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P45, doi. 10.1016/j.jalz.2019.06.4202
- By:
- Publication type:
- Article
Comparison of <sup>18</sup>F‐florbetaben quantification results using the standard Centiloid, MR‐based, and MR‐less CapAIBL<sup>®</sup> approaches: Validation against histopathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 6, p. 807, doi. 10.1016/j.jalz.2019.02.005
- By:
- Publication type:
- Article
P1‐428: APOE STATUS MODULATES BRAIN PATTERNS OF AMYLOID DISTRIBUTION IN INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE (SCD) FROM THE FACEHBI STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P471, doi. 10.1016/j.jalz.2018.06.437
- By:
- Publication type:
- Article
IC‐P‐220: CLINICAL UPDATE: <sup>18</sup>F‐PI‐2620, A NEXT GENERATION TAU PET AGENT EVALUATED IN SUBJECTS WITH ALZHEIMER'S DISEASE AND PROGRESSIVE SUPRANUCLEAR PALSY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P179, doi. 10.1016/j.jalz.2018.06.2287
- By:
- Publication type:
- Article
Added value of <sup>18</sup>F‐florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, n. 3, p. 293, doi. 10.1016/j.jalz.2017.09.009
- By:
- Publication type:
- Article
ADDED VALUE OF FLORBETABEN PET IMAGING ON DIAGNOSIS AND MANAGEMENT IN COMPLEX CASES OF PATIENTS WITH MILD DEMENTIA ELIGIBLE FOR CSF ANALYSIS IN THE FRENCH CLINICAL PRACTICE SETTING.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P409, doi. 10.1016/j.jalz.2017.06.394
- By:
- Publication type:
- Article
COMPARISON OF 18F-FLORBETABEN QUANTIFICATION RESULTS USING MR-BASED AND MR-LESS CAPAIBL: VALIDATION AGAINST HISTOPATHOLOGY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1387, doi. 10.1016/j.jalz.2017.06.2138
- By:
- Publication type:
- Article
COMPARISON OF 18F-FLORBETABEN QUANTIFICATION RESULTS USING MR-BASED AND MR-LESS CAPAIBL: VALIDATION AGAINST HISTOPATHOLOGY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P123, doi. 10.1016/j.jalz.2017.06.2537
- By:
- Publication type:
- Article
METHODOLOGICAL AND LOGISTIC STRATEGIES FOR A LARGE MULTI-CENTER β-AMYLOID PET EUROPEAN PROJECT: AMYLOID IMAGING TO PREVENT ALZHEIMER’S DISEASE (AMYPAD).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P794, doi. 10.1016/j.jalz.2017.06.1074
- By:
- Publication type:
- Article
OPTIMAL REFERENCE REGION TO MEASURE LONGITUDINAL AMYLOID-BETA CHANGE WITH 18F-FLORBETABEN PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P733, doi. 10.1016/j.jalz.2016.06.1531
- By:
- Publication type:
- Article
18F-FLORBETABEN SUVR CUTOFF QUANTIFICATION ACROSS REFERENCE REGIONS AND STANDARDS OF TRUTH AND COMPARISON TO VISUAL ASSESSMENT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P13, doi. 10.1016/j.jalz.2016.06.011
- By:
- Publication type:
- Article
18F-FLORBETABEN SUVR CUTOFF QUANTIFICATION ACROSS REFERENCE REGIONS AND STANDARDS OF TRUTH AND COMPARISON TO VISUAL ASSESSMENT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P1079, doi. 10.1016/j.jalz.2016.06.2256
- By:
- Publication type:
- Article
OPTIMAL REFERENCE REGION TO MEASURE LONGITUDINAL AMYLOID-BETA CHANGE WITH 18F-FLORBETABEN PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P14, doi. 10.1016/j.jalz.2016.06.013
- By:
- Publication type:
- Article
Do cerebellar plaques influence 18F-florbetaben amyloid PET scan quantification?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P286, doi. 10.1016/j.jalz.2015.06.021
- By:
- Publication type:
- Article
A study of optimal SUVR cutpoints and reference regions for florbetaben PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P847, doi. 10.1016/j.jalz.2015.08.006
- By:
- Publication type:
- Article
Impact of morphologically distinct amyloid ß (Aß) deposits on 18F-florbetaben (FBB) PET scans.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P286, doi. 10.1016/j.jalz.2015.06.022
- By:
- Publication type:
- Article
Impact of morphologically distinct amyloid ß (Aß) deposits on 18F-florbetaben (FBB) PET scans.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P14, doi. 10.1016/j.jalz.2015.06.022
- By:
- Publication type:
- Article
Do cerebellar plaques influence 18F-florbetaben amyloid PET scan quantification?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P13, doi. 10.1016/j.jalz.2015.06.021
- By:
- Publication type:
- Article
Evaluation of dosimetry, quantitative methods and test-retest variability of <sup>18</sup>F-PI-2620 PET for the assessment of tau deposits in the human brain.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.236240
- By:
- Publication type:
- Article
Tau PET imaging with <sup>18</sup>F-PI-2620 in patients with Alzheimer’s disease and healthy controls: a first-in-human study.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.236224
- By:
- Publication type:
- Article
Validation of Noninvasive Tracer Kinetic Analysis of <sup>18</sup>F-Florbetaben PET Using a Dual--Time-Window Acquisition Protocol.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 7, p. 1104, doi. 10.2967/jnumed.117.200964
- By:
- Publication type:
- Article
Optimal Reference Region to Measure Longitudinal Amyloid-β Change with <sup>18</sup>F-Florbetaben PET.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 8, p. 1300, doi. 10.2967/jnumed.116.187351
- By:
- Publication type:
- Article
Cerebellar Amyloid-β Plaques: How Frequent Are They, and Do They Influence <sup>18</sup>F-Florbetaben SUV Ratios?
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 11, p. 1740, doi. 10.2967/jnumed.115.171652
- By:
- Publication type:
- Article
Impact of Training Method on the Robustness of the Visual Assessment of <sup>18</sup>F-Florbetaben PET Scans: Results from a Phase-3 Study.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 6, p. 900, doi. 10.2967/jnumed.115.161927
- By:
- Publication type:
- Article
Simulating the effect of cerebral blood flow changes on regional quantification of [ 18 F]flutemetamol and [ 18 F]florbetaben studies.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2021, v. 41, n. 3, p. 579, doi. 10.1177/0271678X20918029
- By:
- Publication type:
- Article
Bilastine vs. hydroxyzine: occupation of brain histamine H<sub>1</sub>-receptors evaluated by positron emission tomography in healthy volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 78, n. 5, p. 970, doi. 10.1111/bcp.12421
- By:
- Publication type:
- Article
Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 11, p. 3276, doi. 10.1007/s00259-023-06279-0
- By:
- Publication type:
- Article
Quantification of amyloid PET for future clinical use: a state-of-the-art review.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 10, p. 3508, doi. 10.1007/s00259-022-05784-y
- By:
- Publication type:
- Article
<sup>18</sup>F-Florbetaben PET beta-amyloid binding expressed in Centiloids.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 12, p. 2053, doi. 10.1007/s00259-017-3749-6
- By:
- Publication type:
- Article
Quantification of dopaminergic neurotransmission SPECT studies with <sup>123</sup>I-labelled radioligands. A comparison between different imaging systems and data acquisition protocols using Monte Carlo simulation.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2008, v. 35, n. 7, p. 1334, doi. 10.1007/s00259-007-0711-z
- By:
- Publication type:
- Article
Translational characterization of [<sup>11</sup>C]GSK931145, a PET ligand for the glycine transporter type 1.
- Published in:
- Synapse, 2011, v. 65, n. 12, p. 1319, doi. 10.1002/syn.20966
- By:
- Publication type:
- Article
Test-retest variability and reliability of <sup>123</sup>I-IBZM SPECT measurement of striatal dopamine D<sub>2</sub> receptor availability in healthy volunteers and influence of iterative reconstruction algorithms.
- Published in:
- Synapse, 2008, v. 62, n. 1, p. 62, doi. 10.1002/syn.20465
- By:
- Publication type:
- Article